Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Control Bionics Ltd

CBL.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Advanced Medical Equipment & Technology ·

Australia Micro Cap Analyst: N/A

Last Close

$0.04

▼ -1.67%

Market Cap $22.60M · Vol 832.90K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$22.60M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

37.14

Momentum

Beta

0.22

vs Market

52W High

$0.07

37.56% below

52W Low

$0.02

99.14% above

Volume

832.90K

Avg 555.11K

P/B

1.60

Price-to-book

ROE

N/A

Return on equity

Free Float

36.58%

Public shares

Shariah Compliance8 STANDARDS

✗ Control Bionics Ltd (CBL.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CBL.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-14.49%

-21.33%

-9.23%

+5.36%

YTD

-3.28%

+43.46%

-9.00%

-90.85%

Financials & Valuation

TTM · Annual

Total Revenue	$4.63M
Net Income	$-4,019,496.00
Revenue Growth (YoY)	-3.35%
Gross Margin	57.13%
Operating Margin	-84.10%
Net Profit Margin	-86.77%
ROE	N/A
ROA · ROIC	-70.78% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.13
P/B	1.60
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	543.09M

Technical Indicators

50-Day SMA	$0.05
200-Day SMA	$0.05
RSI (14)	37.14
Beta	0.22
52-Week High	$0.07
52-Week Low	$0.02

Volume Today	832.90K
Avg Daily Volume (30D)	555.11K
Relative Volume	1.50x
Volatility (10D)	63.83
Volatility (30D)	70.81
Free Float	36.58%

Analyst Consensus

N/A

Current Price $0.04

Mean Target N/A

52W Low$0.02 52W High$0.07

Current

Target

$0.02 $0.07

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG00Y540MB0

ISINAU0000114183

CountryAustralia

Sub-IndustryMedical Diagnostic & Testing Equipment

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SRT.DE Sartorius AG -1.14% BIOT.ST Biotage AB +0.14% EUZ.DE Eckert & Ziegler SE -0.44% VREX Varex Imaging Corp -0.05% REG1V.HE Revenio Group Oyj +5.89%

Company Profile

Control Bionics Limited is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses, such as Motor Neurone Disease and Amyotrophic Lateral Sclerosis. Its products include Control Bionics Trilogy Systems, NeuroStrip, NeuroNode, Cosmos Connect and accessories. NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as electromyography output. This output is then sent wirelessly via NeuroNode to a personal computer, enabling speech and other computer-controlled functions like email and texting. Its technology is integrated with eye gaze technology whereby the eye gaze enables a cursor to be moved about a computer screen, driven much like a mouse and the NeuroNode acts like a mouse button. It is commercializing its advancement in its technology, NeuroStrip. It is focused on neuromuscular rehabilitation and athletic optimization.